IPP Bureau
Remedium Lifecare charts 4X growth strategy
By IPP Bureau - August 26, 2025
The first pillar is advanced manufacturing, focused on upgrading existing CDMO
CuraTeQ Biologics receives approval for biosimilar Dazublys from UK's MHRA
By IPP Bureau - August 26, 2025
Earlier in July 2025, Dazublys has received the marketing authorisation in the European Union from the European Commission
Giant antibody in humans acts like a brace against bacterial toxins
By IPP Bureau - August 26, 2025
Protein L is known as a “superantigen” because it can bind antibodies in unusual ways
India releases first-ever National Guidelines/SOPs for animal blood transfusion and blood banks
By IPP Bureau - August 26, 2025
Guidelines aim to establish state-regulated veterinary blood banks
Terumo India launches Terufusion advanced infusion systems in India
By IPP Bureau - August 26, 2025
Terufusion Advanced Infusion Systems combine a smart syringe pump, smart infusion pump, and pump monitoring system software for precise and efficient drug administration
Eris Lifesciences receives ANVISA approval for sterile injectable facility
By IPP Bureau - August 26, 2025
Gland Pharma receives FDA approval for Vasopressin in 5% Dextrose RTU Injection
By IPP Bureau - August 26, 2025
The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), VASOSTRICT Injection 40 Units per 100 mL and 20 Units per 100 mL of PH Health Limited
Dr. Reddy's launches novel drug for chronic constipation management
By IPP Bureau - August 26, 2025
Dr. Reddy’s becomes the first pharmaceutical company to receive regulatory approval to launch Linaclotide in India under the brand name Colozo
Nanavati Max Hospital performs 4-hour simultaneous pancreas-kidney transplant on 25-year-old with Type-1 diabetes
By IPP Bureau - August 26, 2025
The complex four-hour surgery was performed by a multidisciplinary team of doctors
Roche’s US subsidiary Genentech breaks ground on $700 million manufacturing facility in North Carolina
By IPP Bureau - August 26, 2025
The $700 million project is part of Roche’s $50 billion investment in US manufacturing, infrastructure and R&D
J&J to invest $2 billion at CDMO Fujifilm’s new hub
By IPP Bureau - August 25, 2025
Investment supports Company’s plans to manufacture the vast majority of advanced medicines in the U.S. to meet the needs of patients in the U.S.
Parexel appoints Jim Anthony as CCO and President, Parexel Biotech
By IPP Bureau - August 25, 2025
Anthony brings more than 25 years of pharmaceutical development and CRO experience to his expanded role
Enanta files patent infringement suit against Pfizer
By IPP Bureau - August 25, 2025
The ‘265 Patent is based on Enanta’s July 2020 patent application describing coronavirus protease inhibitors invented by Enanta scientists
Boehringer and AnGes sign manufacturing agreement for HGF gene therapy product
By IPP Bureau - August 25, 2025
Collaboration reinforces Boehringer Ingelheim’s expertise in microbial contract development and manufacturing
FDA grants ODD to Keros KER-065 for treatment of Duchenne muscular dystrophy
By IPP Bureau - August 25, 2025
KER-065 is a novel ligand trap comprised of a modified ligand-binding domain derived from activin receptor type IIA and activin receptor type IIB
